APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medicated Adhesive Patch

Compare research editions
View pricing & licenses

Selected research

Industry Research

Medicated Adhesive Patch Industry Research Report 2026

Report ID 173822960523 December 2025130 pages

Choose your research edition.

Industry ResearchMedicated Adhesive Patch Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Medicated Adhesive Patch Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Medicated Adhesive Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medicated Adhesive Patch Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Medicated Adhesive Patch Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Medicated Adhesive Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Medicated Adhesive Patch is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Medicated Adhesive Patch is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Medicated Adhesive Patch is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Medicated Adhesive Patch include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Medicated Adhesive Patch market in revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Medicated Adhesive Patch.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Medicated Adhesive Patch Market by Company

Johnson & Johnson

Novartis

Mylan

Pfizer

GSK

Beijing Tide Pharmaceutical

Bayer

UCB Pharma

Teva Pharmaceutical

Nitto Denko

Mundipharma

Luye Pharma Group

IBSA Group

Hisamitsu Pharmaceutical

Grünenthal

Endo International

Dr Reddy’s Laboratories

Chattem

Medicated Adhesive Patch Segment by Type

Methyl Salicylate-based Patch

Nicotine Transdermal Patch

Rivastigmine Transdermal Patch

Clonidine Transdermal Patch

Fentanyl Transdermal Patch

Oxybutynin Transdermal Patch

Others

Medicated Adhesive Patch Segment by Application

Used to Treat High Blood Pressure

Used to Treat an Overactive Bladder

Used to Relieve Severe Pain

Used to Stop Smoking Cigarettes

Others

Medicated Adhesive Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicated Adhesive Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medicated Adhesive Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicated Adhesive Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Medicated Adhesive Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Medicated Adhesive Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Medicated Adhesive Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Medicated Adhesive Patch Production by Manufacturers (K Units) & (2021-2026) Table 6. Global Medicated Adhesive Patch Production Market Share by Manufacturers Table 7. Global Medicated Adhesive Patch Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Medicated Adhesive Patch Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Medicated Adhesive Patch Average Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Medicated Adhesive Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Medicated Adhesive Patch Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Medicated Adhesive Patch Manufacturers, Product Type & Application Table 13. Global Medicated Adhesive Patch Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Medicated Adhesive Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Johnson & Johnson Company Information Table 18. Johnson & Johnson Business Overview Table 19. Johnson & Johnson Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 20. Johnson & Johnson Medicated Adhesive Patch Product Portfolio Table 21. Johnson & Johnson Recent Development Table 22. Novartis Company Information Table 23. Novartis Business Overview Table 24. Novartis Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 25. Novartis Medicated Adhesive Patch Product Portfolio Table 26. Novartis Recent Development Table 27. Mylan Company Information Table 28. Mylan Business Overview Table 29. Mylan Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 30. Mylan Medicated Adhesive Patch Product Portfolio Table 31. Mylan Recent Development Table 32. Pfizer Company Information Table 33. Pfizer Business Overview Table 34. Pfizer Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 35. Pfizer Medicated Adhesive Patch Product Portfolio Table 36. Pfizer Recent Development Table 37. GSK Company Information Table 38. GSK Business Overview Table 39. GSK Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 40. GSK Medicated Adhesive Patch Product Portfolio Table 41. GSK Recent Development Table 42. Beijing Tide Pharmaceutical Company Information Table 43. Beijing Tide Pharmaceutical Business Overview Table 44. Beijing Tide Pharmaceutical Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Beijing Tide Pharmaceutical Medicated Adhesive Patch Product Portfolio Table 46. Beijing Tide Pharmaceutical Recent Development Table 47. Bayer Company Information Table 48. Bayer Business Overview Table 49. Bayer Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 50. Bayer Medicated Adhesive Patch Product Portfolio Table 51. Bayer Recent Development Table 52. UCB Pharma Company Information Table 53. UCB Pharma Business Overview Table 54. UCB Pharma Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 55. UCB Pharma Medicated Adhesive Patch Product Portfolio Table 56. UCB Pharma Recent Development Table 57. Teva Pharmaceutical Company Information Table 58. Teva Pharmaceutical Business Overview Table 59. Teva Pharmaceutical Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Teva Pharmaceutical Medicated Adhesive Patch Product Portfolio Table 61. Teva Pharmaceutical Recent Development Table 62. Nitto Denko Company Information Table 63. Nitto Denko Business Overview Table 64. Nitto Denko Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Nitto Denko Medicated Adhesive Patch Product Portfolio Table 66. Nitto Denko Recent Development Table 67. Mundipharma Company Information Table 68. Mundipharma Business Overview Table 69. Mundipharma Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Mundipharma Medicated Adhesive Patch Product Portfolio Table 71. Mundipharma Recent Development Table 72. Luye Pharma Group Company Information Table 73. Luye Pharma Group Business Overview Table 74. Luye Pharma Group Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Luye Pharma Group Medicated Adhesive Patch Product Portfolio Table 76. Luye Pharma Group Recent Development Table 77. IBSA Group Company Information Table 78. IBSA Group Business Overview Table 79. IBSA Group Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. IBSA Group Medicated Adhesive Patch Product Portfolio Table 81. IBSA Group Recent Development Table 82. Hisamitsu Pharmaceutical Company Information Table 83. Hisamitsu Pharmaceutical Business Overview Table 84. Hisamitsu Pharmaceutical Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Hisamitsu Pharmaceutical Medicated Adhesive Patch Product Portfolio Table 86. Hisamitsu Pharmaceutical Recent Development Table 87. Grünenthal Company Information Table 88. Grünenthal Business Overview Table 89. Grünenthal Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Grünenthal Medicated Adhesive Patch Product Portfolio Table 91. Grünenthal Recent Development Table 92. Endo International Company Information Table 93. Endo International Business Overview Table 94. Endo International Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Endo International Medicated Adhesive Patch Product Portfolio Table 96. Endo International Recent Development Table 97. Dr Reddy’s Laboratories Company Information Table 98. Dr Reddy’s Laboratories Business Overview Table 99. Dr Reddy’s Laboratories Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Dr Reddy’s Laboratories Medicated Adhesive Patch Product Portfolio Table 101. Dr Reddy’s Laboratories Recent Development Table 102. Chattem Company Information Table 103. Chattem Business Overview Table 104. Chattem Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Chattem Medicated Adhesive Patch Product Portfolio Table 106. Chattem Recent Development Table 107. Global Medicated Adhesive Patch Production Comparison by Region: 2021 VS 2025 VS 2032 (K Units) Table 108. Global Medicated Adhesive Patch Production by Region (2021-2026) & (K Units) Table 109. Global Medicated Adhesive Patch Production Market Share by Region (2021-2026) Table 110. Global Medicated Adhesive Patch Production Forecast by Region (2027-2032) & (K Units) Table 111. Global Medicated Adhesive Patch Production Market Share Forecast by Region (2027-2032) Table 112. Global Medicated Adhesive Patch Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Global Medicated Adhesive Patch Production Value by Region (2021-2026) & (US$ Million) Table 114. Global Medicated Adhesive Patch Production Value Market Share by Region (2021-2026) Table 115. Global Medicated Adhesive Patch Production Value Forecast by Region (2027-2032) & (US$ Million) Table 116. Global Medicated Adhesive Patch Market Average Price (US$/unit) by Region (2021-2026) Table 117. Global Medicated Adhesive Patch Market Average Price (US$/unit) by Region (2027-2032) Table 118. Global Medicated Adhesive Patch Consumption Comparison by Region: 2021 VS 2025 VS 2032 (K Units) Table 119. Global Medicated Adhesive Patch Consumption by Region (2021-2026) & (K Units) Table 120. Global Medicated Adhesive Patch Consumption Market Share by Region (2021-2026) Table 121. Global Medicated Adhesive Patch Forecasted Consumption by Region (2027-2032) & (K Units) Table 122. Global Medicated Adhesive Patch Forecasted Consumption Market Share by Region (2027-2032) Table 123. North America Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 124. North America Medicated Adhesive Patch Consumption by Country (2021-2026) & (K Units) Table 125. North America Medicated Adhesive Patch Consumption by Country (2027-2032) & (K Units) Table 126. Europe Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 127. Europe Medicated Adhesive Patch Consumption by Country (2021-2026) & (K Units) Table 128. Europe Medicated Adhesive Patch Consumption by Country (2027-2032) & (K Units) Table 129. Asia Pacific Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 130. Asia Pacific Medicated Adhesive Patch Consumption by Country (2021-2026) & (K Units) Table 131. Asia Pacific Medicated Adhesive Patch Consumption by Country (2027-2032) & (K Units) Table 132. South America, Middle East & Africa Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 133. South America, Middle East & Africa Medicated Adhesive Patch Consumption by Country (2021-2026) & (K Units) Table 134. South America, Middle East & Africa Medicated Adhesive Patch Consumption by Country (2027-2032) & (K Units) Table 135. Global Medicated Adhesive Patch Production by Type (2021-2026) & (K Units) Table 136. Global Medicated Adhesive Patch Production by Type (2027-2032) & (K Units) Table 137. Global Medicated Adhesive Patch Production Market Share by Type (2021-2026) Table 138. Global Medicated Adhesive Patch Production Market Share by Type (2027-2032) Table 139. Global Medicated Adhesive Patch Production Value by Type (2021-2026) & (US$ Million) Table 140. Global Medicated Adhesive Patch Production Value by Type (2027-2032) & (US$ Million) Table 141. Global Medicated Adhesive Patch Production Value Market Share by Type (2021-2026) Table 142. Global Medicated Adhesive Patch Production Value Market Share by Type (2027-2032) Table 143. Global Medicated Adhesive Patch Price by Type (2021-2026) & (US$/unit) Table 144. Global Medicated Adhesive Patch Price by Type (2027-2032) & (US$/unit) Table 145. Global Medicated Adhesive Patch Production by Application (2021-2026) & (K Units) Table 146. Global Medicated Adhesive Patch Production by Application (2027-2032) & (K Units) Table 147. Global Medicated Adhesive Patch Production Market Share by Application (2021-2026) Table 148. Global Medicated Adhesive Patch Production Market Share by Application (2027-2032) Table 149. Global Medicated Adhesive Patch Production Value by Application (2021-2026) & (US$ Million) Table 150. Global Medicated Adhesive Patch Production Value by Application (2027-2032) & (US$ Million) Table 151. Global Medicated Adhesive Patch Production Value Market Share by Application (2021-2026) Table 152. Global Medicated Adhesive Patch Production Value Market Share by Application (2027-2032) Table 153. Global Medicated Adhesive Patch Price by Application (2021-2026) & (US$/unit) Table 154. Global Medicated Adhesive Patch Price by Application (2027-2032) & (US$/unit) Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Medicated Adhesive Patch Distributors List Table 158. Medicated Adhesive Patch Customers List Table 159. Medicated Adhesive Patch Industry Trends Table 160. Medicated Adhesive Patch Industry Drivers Table 161. Medicated Adhesive Patch Industry Restraints Table 162. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Medicated Adhesive Patch Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Methyl Salicylate-based Patch Product Image Figure 7. Nicotine Transdermal Patch Product Image Figure 8. Rivastigmine Transdermal Patch Product Image Figure 9. Clonidine Transdermal Patch Product Image Figure 10. Fentanyl Transdermal Patch Product Image Figure 11. Oxybutynin Transdermal Patch Product Image Figure 12. Others Product Image Figure 13. Used to Treat High Blood Pressure Product Image Figure 14. Used to Treat an Overactive Bladder Product Image Figure 15. Used to Relieve Severe Pain Product Image Figure 16. Used to Stop Smoking Cigarettes Product Image Figure 17. Others Product Image Figure 18. Global Medicated Adhesive Patch Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Medicated Adhesive Patch Production Value (2021-2032) & (US$ Million) Figure 20. Global Medicated Adhesive Patch Production Capacity (2021-2032) & (K Units) Figure 21. Global Medicated Adhesive Patch Production (2021-2032) & (K Units) Figure 22. Global Medicated Adhesive Patch Average Price (US$/unit) & (2021-2032) Figure 23. Global Medicated Adhesive Patch Key Manufacturers, Manufacturing Sites & Headquarters Figure 24. Global Top 5 and 10 Medicated Adhesive Patch Players Market Share by Production Value in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Medicated Adhesive Patch Production Comparison by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Medicated Adhesive Patch Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Medicated Adhesive Patch Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Medicated Adhesive Patch Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Medicated Adhesive Patch Production Value (US$ Million) Growth Rate (2021-2032) Figure 31. Europe Medicated Adhesive Patch Production Value (US$ Million) Growth Rate (2021-2032) Figure 32. China Medicated Adhesive Patch Production Value (US$ Million) Growth Rate (2021-2032) Figure 33. Japan Medicated Adhesive Patch Production Value (US$ Million) Growth Rate (2021-2032) Figure 34. Global Medicated Adhesive Patch Consumption Comparison by Region: 2021 VS 2025 VS 2032 (K Units) Figure 35. Global Medicated Adhesive Patch Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 37. North America Medicated Adhesive Patch Consumption Market Share by Country (2021-2032) Figure 38. United States Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 39. United States Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 40. Canada Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 41. Mexico Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 42. Europe Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 43. Europe Medicated Adhesive Patch Consumption Market Share by Country (2021-2032) Figure 44. Germany Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 45. France Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 46. U.K. Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 47. Italy Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 48. Russia Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 49. Spain Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 50. Netherlands Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 51. Switzerland Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 52. Sweden Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 53. Poland Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 54. Asia Pacific Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 55. Asia Pacific Medicated Adhesive Patch Consumption Market Share by Country (2021-2032) Figure 56. China Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 57. Japan Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 58. South Korea Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 59. India Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 60. Australia Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 61. Taiwan Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 62. Southeast Asia Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 63. South America, Middle East & Africa Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 64. South America, Middle East & Africa Medicated Adhesive Patch Consumption Market Share by Country (2021-2032) Figure 65. Brazil Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 66. Argentina Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 67. Chile Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 68. Turkey Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 69. GCC Countries Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 70. Global Medicated Adhesive Patch Production Market Share by Type (2021-2032) Figure 71. Global Medicated Adhesive Patch Production Value Market Share by Type (2021-2032) Figure 72. Global Medicated Adhesive Patch Price (US$/unit) by Type (2021-2032) Figure 73. Global Medicated Adhesive Patch Production Market Share by Application (2021-2032) Figure 74. Global Medicated Adhesive Patch Production Value Market Share by Application (2021-2032) Figure 75. Global Medicated Adhesive Patch Price (US$/unit) by Application (2021-2032) Figure 76. Medicated Adhesive Patch Value Chain Figure 77. Medicated Adhesive Patch Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Medicated Adhesive Patch Industry Opportunities and Challenges

Scope & coverage.

Types
  • Methyl Salicylate-based Patch
  • Nicotine Transdermal Patch
  • Rivastigmine Transdermal Patch
  • Clonidine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Oxybutynin Transdermal Patch
  • Others
Applications
  • Used to Treat High Blood Pressure
  • Used to Treat an Overactive Bladder
  • Used to Relieve Severe Pain
  • Used to Stop Smoking Cigarettes
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Beijing Tide Pharmaceutical
  • Bayer
  • UCB Pharma
  • Teva Pharmaceutical
  • Nitto Denko
  • Mundipharma
  • Luye Pharma Group
  • IBSA Group
  • Hisamitsu Pharmaceutical
  • Grünenthal
  • Endo International
  • Dr Reddy’s Laboratories
  • Chattem

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Medicated Adhesive Patch by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 Methyl Salicylate-based Patch
  5. 2.2.3 Nicotine Transdermal Patch
  6. 2.2.4 Rivastigmine Transdermal Patch
  7. 2.2.5 Clonidine Transdermal Patch
  8. 2.2.6 Fentanyl Transdermal Patch
  9. 2.2.7 Oxybutynin Transdermal Patch
  10. 2.2.8 Others
  11. 2.3 Medicated Adhesive Patch by Application
  12. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  13. 2.3.2 Used to Treat High Blood Pressure
  14. 2.3.3 Used to Treat an Overactive Bladder
  15. 2.3.4 Used to Relieve Severe Pain
  16. 2.3.5 Used to Stop Smoking Cigarettes
  17. 2.3.6 Others
  18. 2.4 Global Market Growth Prospects
  19. 2.4.1 Global Medicated Adhesive Patch Production Value Estimates and Forecasts (2021-2032)
  20. 2.4.2 Global Medicated Adhesive Patch Production Capacity Estimates and Forecasts (2021-2032)
  21. 2.4.3 Global Medicated Adhesive Patch Production Estimates and Forecasts (2021-2032)
  22. 2.4.4 Global Medicated Adhesive Patch Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Medicated Adhesive Patch Production by Manufacturers (2021-2026)
  2. 3.2 Global Medicated Adhesive Patch Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Medicated Adhesive Patch Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Medicated Adhesive Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medicated Adhesive Patch Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Medicated Adhesive Patch Manufacturers, Product Type & Application
  7. 3.7 Global Medicated Adhesive Patch Manufacturers Established Date
  8. 3.8 Global Medicated Adhesive Patch Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Johnson & Johnson
  2. 4.1.1 Johnson & Johnson Medicated Adhesive Patch Company Information
  3. 4.1.2 Johnson & Johnson Medicated Adhesive Patch Business Overview
  4. 4.1.3 Johnson & Johnson Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  5. 4.1.4 Johnson & Johnson Product Portfolio
  6. 4.1.5 Johnson & Johnson Recent Developments
  7. 4.2 Novartis
  8. 4.2.1 Novartis Medicated Adhesive Patch Company Information
  9. 4.2.2 Novartis Medicated Adhesive Patch Business Overview
  10. 4.2.3 Novartis Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  11. 4.2.4 Novartis Product Portfolio
  12. 4.2.5 Novartis Recent Developments
  13. 4.3 Mylan
  14. 4.3.1 Mylan Medicated Adhesive Patch Company Information
  15. 4.3.2 Mylan Medicated Adhesive Patch Business Overview
  16. 4.3.3 Mylan Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  17. 4.3.4 Mylan Product Portfolio
  18. 4.3.5 Mylan Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Medicated Adhesive Patch Company Information
  21. 4.4.2 Pfizer Medicated Adhesive Patch Business Overview
  22. 4.4.3 Pfizer Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 GSK
  26. 4.5.1 GSK Medicated Adhesive Patch Company Information
  27. 4.5.2 GSK Medicated Adhesive Patch Business Overview
  28. 4.5.3 GSK Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  29. 4.5.4 GSK Product Portfolio
  30. 4.5.5 GSK Recent Developments
  31. 4.6 Beijing Tide Pharmaceutical
  32. 4.6.1 Beijing Tide Pharmaceutical Medicated Adhesive Patch Company Information
  33. 4.6.2 Beijing Tide Pharmaceutical Medicated Adhesive Patch Business Overview
  34. 4.6.3 Beijing Tide Pharmaceutical Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  35. 4.6.4 Beijing Tide Pharmaceutical Product Portfolio
  36. 4.6.5 Beijing Tide Pharmaceutical Recent Developments
  37. 4.7 Bayer
  38. 4.7.1 Bayer Medicated Adhesive Patch Company Information
  39. 4.7.2 Bayer Medicated Adhesive Patch Business Overview
  40. 4.7.3 Bayer Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  41. 4.7.4 Bayer Product Portfolio
  42. 4.7.5 Bayer Recent Developments
  43. 4.8 UCB Pharma
  44. 4.8.1 UCB Pharma Medicated Adhesive Patch Company Information
  45. 4.8.2 UCB Pharma Medicated Adhesive Patch Business Overview
  46. 4.8.3 UCB Pharma Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  47. 4.8.4 UCB Pharma Product Portfolio
  48. 4.8.5 UCB Pharma Recent Developments
  49. 4.9 Teva Pharmaceutical
  50. 4.9.1 Teva Pharmaceutical Medicated Adhesive Patch Company Information
  51. 4.9.2 Teva Pharmaceutical Medicated Adhesive Patch Business Overview
  52. 4.9.3 Teva Pharmaceutical Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  53. 4.9.4 Teva Pharmaceutical Product Portfolio
  54. 4.9.5 Teva Pharmaceutical Recent Developments
  55. 4.10 Nitto Denko
  56. 4.10.1 Nitto Denko Medicated Adhesive Patch Company Information
  57. 4.10.2 Nitto Denko Medicated Adhesive Patch Business Overview
  58. 4.10.3 Nitto Denko Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  59. 4.10.4 Nitto Denko Product Portfolio
  60. 4.10.5 Nitto Denko Recent Developments
  61. 4.11 Mundipharma
  62. 4.11.1 Mundipharma Medicated Adhesive Patch Company Information
  63. 4.11.2 Mundipharma Medicated Adhesive Patch Business Overview
  64. 4.11.3 Mundipharma Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  65. 4.11.4 Mundipharma Product Portfolio
  66. 4.11.5 Mundipharma Recent Developments
  67. 4.12 Luye Pharma Group
  68. 4.12.1 Luye Pharma Group Medicated Adhesive Patch Company Information
  69. 4.12.2 Luye Pharma Group Medicated Adhesive Patch Business Overview
  70. 4.12.3 Luye Pharma Group Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  71. 4.12.4 Luye Pharma Group Product Portfolio
  72. 4.12.5 Luye Pharma Group Recent Developments
  73. 4.13 IBSA Group
  74. 4.13.1 IBSA Group Medicated Adhesive Patch Company Information
  75. 4.13.2 IBSA Group Medicated Adhesive Patch Business Overview
  76. 4.13.3 IBSA Group Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  77. 4.13.4 IBSA Group Product Portfolio
  78. 4.13.5 IBSA Group Recent Developments
  79. 4.14 Hisamitsu Pharmaceutical
  80. 4.14.1 Hisamitsu Pharmaceutical Medicated Adhesive Patch Company Information
  81. 4.14.2 Hisamitsu Pharmaceutical Medicated Adhesive Patch Business Overview
  82. 4.14.3 Hisamitsu Pharmaceutical Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  83. 4.14.4 Hisamitsu Pharmaceutical Product Portfolio
  84. 4.14.5 Hisamitsu Pharmaceutical Recent Developments
  85. 4.15 Grünenthal
  86. 4.15.1 Grünenthal Medicated Adhesive Patch Company Information
  87. 4.15.2 Grünenthal Medicated Adhesive Patch Business Overview
  88. 4.15.3 Grünenthal Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  89. 4.15.4 Grünenthal Product Portfolio
  90. 4.15.5 Grünenthal Recent Developments
  91. 4.16 Endo International
  92. 4.16.1 Endo International Medicated Adhesive Patch Company Information
  93. 4.16.2 Endo International Medicated Adhesive Patch Business Overview
  94. 4.16.3 Endo International Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  95. 4.16.4 Endo International Product Portfolio
  96. 4.16.5 Endo International Recent Developments
  97. 4.17 Dr Reddy’s Laboratories
  98. 4.17.1 Dr Reddy’s Laboratories Medicated Adhesive Patch Company Information
  99. 4.17.2 Dr Reddy’s Laboratories Medicated Adhesive Patch Business Overview
  100. 4.17.3 Dr Reddy’s Laboratories Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  101. 4.17.4 Dr Reddy’s Laboratories Product Portfolio
  102. 4.17.5 Dr Reddy’s Laboratories Recent Developments
  103. 4.18 Chattem
  104. 4.18.1 Chattem Medicated Adhesive Patch Company Information
  105. 4.18.2 Chattem Medicated Adhesive Patch Business Overview
  106. 4.18.3 Chattem Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  107. 4.18.4 Chattem Product Portfolio
  108. 4.18.5 Chattem Recent Developments
5 Global Medicated Adhesive Patch Production by Region
  1. 5.1 Global Medicated Adhesive Patch Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Medicated Adhesive Patch Production by Region: 2021-2032
  3. 5.2.1 Global Medicated Adhesive Patch Production by Region: 2021-2026
  4. 5.2.2 Global Medicated Adhesive Patch Production Forecast by Region (2027-2032)
  5. 5.3 Global Medicated Adhesive Patch Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Medicated Adhesive Patch Production Value by Region: 2021-2032
  7. 5.4.1 Global Medicated Adhesive Patch Production Value by Region: 2021-2026
  8. 5.4.2 Global Medicated Adhesive Patch Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Medicated Adhesive Patch Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Medicated Adhesive Patch Production and Value, YOY Growth
  11. 5.6.1 North America Medicated Adhesive Patch Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Medicated Adhesive Patch Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Medicated Adhesive Patch Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Medicated Adhesive Patch Production Value Estimates and Forecasts (2021-2032)
6 Global Medicated Adhesive Patch Consumption by Region
  1. 6.1 Global Medicated Adhesive Patch Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medicated Adhesive Patch Consumption by Region (2021-2032)
  3. 6.2.1 Global Medicated Adhesive Patch Consumption by Region: 2021-2026
  4. 6.2.2 Global Medicated Adhesive Patch Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Medicated Adhesive Patch Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Medicated Adhesive Patch Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Medicated Adhesive Patch Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Medicated Adhesive Patch Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Medicated Adhesive Patch Production by Type (2021-2032)
  2. 7.1.1 Global Medicated Adhesive Patch Production by Type (2021-2032) & (K Units)
  3. 7.1.2 Global Medicated Adhesive Patch Production Market Share by Type (2021-2032)
  4. 7.2 Global Medicated Adhesive Patch Production Value by Type (2021-2032)
  5. 7.2.1 Global Medicated Adhesive Patch Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Medicated Adhesive Patch Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Medicated Adhesive Patch Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Medicated Adhesive Patch Production by Application (2021-2032)
  2. 8.1.1 Global Medicated Adhesive Patch Production by Application (2021-2032) & (K Units)
  3. 8.1.2 Global Medicated Adhesive Patch Production Market Share by Application (2021-2032)
  4. 8.2 Global Medicated Adhesive Patch Production Value by Application (2021-2032)
  5. 8.2.1 Global Medicated Adhesive Patch Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Medicated Adhesive Patch Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Medicated Adhesive Patch Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Medicated Adhesive Patch Value Chain Analysis
  2. 9.1.1 Medicated Adhesive Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Medicated Adhesive Patch Production Mode & Process
  5. 9.2 Medicated Adhesive Patch Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Medicated Adhesive Patch Distributors
  8. 9.2.3 Medicated Adhesive Patch Customers
10 Global Medicated Adhesive Patch Analyzing Market Dynamics
  1. 10.1 Medicated Adhesive Patch Industry Trends
  2. 10.2 Medicated Adhesive Patch Industry Drivers
  3. 10.3 Medicated Adhesive Patch Industry Opportunities and Challenges
  4. 10.4 Medicated Adhesive Patch Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst